← Oncology Approval Tracker

FDA DECISION ·

Fyarro

sirolimus protein-bound particles (albumin-bound) · Aadi Bioscience

FDA approvalNew therapyMalignant perivascular epithelioid cell tumor
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adults with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor.

LAMPGEN ANALYSIS

Why it matters

This approval establishes a systemic option for a rare sarcoma with a distinct formulation of sirolimus.

What research teams should watch

Use histology review to confirm malignant PEComa and capture when surgery was deemed infeasible.

PRIMARY RECORDS

Sources